Global In Vitro Diagnostics (IVD) Market which is expected to reach to US$ 71.8 billion by the end of the year 2020

0

Global In Vitro Diagnostics (IVD) Market which is expected to reach to US$ 71.8 billion by the end of the year 2020

In Vitro Diagnostics(IVD) Market provides an in-depth analysis of global IVD market which is expected to reach to US$ 71.8 billion by the end of the year 2020.

PUNE, INDIA, November 8, 2016 /EINPresswire.com/ — The report ‘Global In Vitro Diagnostics (IVD) Market by Technology (Immunodiagnostics, Molecular Diagnostics, Clinical Chemistry) and by Product Type(Reagents, Instrument Services and Instrumentation) Outlook 2020” provides an in-depth analysis of global IVD market which is expected to reach to US$ 71.8 billion by the end of the year 2020. The report is segmented on the basis of major technologies used and product categories with detailed current and forecasted market outlook.

Growth of the industry is driven by increasing prevalence of chronic and infectious diseases, growing geriatric population, implementation of the Affordable Care Act (ACA) and rise in demand for Point of Care facilities. However, complex regulatory framework and cumbersome reimbursement policy are the major factors restraining the growth of IVD industry. Global IoT Transportation market is dominated by few major companies, of which Abbott Laboratories, Roche Holding AG, Siemens AG and Danaher Corporation have been profiled in the report.

View Sample Report @ https://www.wiseguyreports.com/sample-request/721397-global-in-vitro-diagnostics-instrumentation-outlook-2020

Market Segmentation by Products
• Reagents
• Instrumentation
• Instrument Services

Market Segmentation by Technology
• Immunodiagnostics
• Clinical Chemistry
• Molecular Diagnostic

Key Vendors
• Abbott Laboratories
• Roche Holding AG
• Siemens AG
• Danaher Corporation

Access Report @ https://www.wiseguyreports.com/reports/721397-global-in-vitro-diagnostics-instrumentation-outlook-2020

Table of Content

1. Executive Summary
2. Research Methodology
3. In Vitro Diagnostics
3.1 Overview
3.2 Market Analysis
3.2.1 Market Size by Value (Actual & Forecasted)
4. IVD Market Segmentation
4.1 By Products
4.1.1 Global IVD Market Share by Product Type (Actual & Forecasted)
4.2 By Test Location
4.2.1 Global IVD Market Share by Test Location
4.3 By Discipline
4.3.1 Global IVD Market Share by Discipline
4.4 By Application
5. Global In Vitro Diagnostics (IVD) Market Segmentation
5.1 Product Analysis
5.1.1 Global IVD Reagents Market Size (Actual & Forecasted)
5.1.2 Global IVD Instrumentation Market Size (Actual & Forecasted)
5.1.3 IVD Instrumentation Market by Segment
5.1.4 Global IVD Instrument Services Market Size (Actual & Forecasted)
5.2 Technological Analysis
5.2.1 Global Immunodiagnostics Market Size (Actual & Forecasted)
5.2.2 Global Clinical Chemistry Market Size (Actual & Forecasted)
5.2.3 Global Molecular Diagnostics Market Size (Actual & Forecasted)
6. Global In Vitro Diagnostics (IVD) Market Regional Analysis
6.1 European IVD Market Analysis
6.1.1 European IVD Market Size (Actual & Forecasted)
6.1.2 European IVD Market- Country Analysis
7. Market Dynamics
7.1 Growth Drivers
7.1.1 Increasing prevalence of chronic and infectious diseases
7.1.2 Growing geriatric population
7.1.3 Implementation of the Affordable Care Act (ACA)
7.1.4 Demand for Point of Care facilities
7.2 Challenges
7.2.1 Complex Regulatory Framework
7.2.2 Cumbersome Reimbursement Policy
8. Global IVD Market Trends
8.1 VC Funding & IPOs in IVD Market
8.2 Point-of-care(POC) Molecular Test Products
8.3 Emergence of Targeted Genomic Therapies
9. Competitive Landscape
9.1 IVD Market Share by Competitors (Actual & Forecasted)
9.2 Competitors Capability Analysis
10. Company Profiles
10.1 Abbott Laboratories, Inc.
10.1.1 Business Overview
10.1.2 Financial Overview
10.1.3 Business Strategies
10.2 Roche Holding AG
10.2.1 Business Overview
10.2.2 Financial Overview
10.2.3 Business Strategies
10.3 Siemens AG
10.3.1 Business Overview
10.3.2 Financial Overview
10.3.3 Business Strategies
10.4 Danaher Corporation
10.4.1 Business Overview
10.4.2 Financial Overview
10.4.3 Business Strategies

…CONTINUED

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=721397

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: